Mounjaro In India
-
{
- All
- News
- Web Stories
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
How A YouTuber Lost 10 Kg With Mounjaro And What It Did To His Emotions: 'Life Was Flat'
A YouTuber shared that while he lost 10 kg with Mounjaro, he also felt deprived of emotions. Irrespective of the situation, he remained neutral
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
Mounjaro For Weight Loss Becomes Second-Highest Selling Drug In India In 6 Months
Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
How A YouTuber Lost 10 Kg With Mounjaro And What It Did To His Emotions: 'Life Was Flat'
A YouTuber shared that while he lost 10 kg with Mounjaro, he also felt deprived of emotions. Irrespective of the situation, he remained neutral
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
Mounjaro For Weight Loss Becomes Second-Highest Selling Drug In India In 6 Months
Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore
